MOH — authorised 27 November 2013
- Marketing authorisation holder: VIFOR FRESENIUS
- Status: likely_approved
🇮🇱 Ferrlecit in Israel
MOH authorised Ferrlecit on 27 November 2013
Marketing authorisation
Ferrlecit in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in Israel
Frequently asked questions
Is Ferrlecit approved in Israel?
Yes. MOH authorised it on 27 November 2013.
Who is the marketing authorisation holder for Ferrlecit in Israel?
VIFOR FRESENIUS holds the Israeli marketing authorisation.